ConductScience.org, home

Paper2427240

Pharmacokinetic study of fludarabine phosphate (NSC 312887).

Hersh MR and 5 others. Cancer Chemother Pharmacol, 1986. Cited by 72 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetic study of fludarabine phosphate (NSC 312887). Papers, record 2427240. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2427240

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetic study of fludarabine phosphate (NSC 312887).
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
72
iCite
Relative citation ratio, by iCite
2.72
iCite
Revised in PubMed
2019-08-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hersh MRM R
2Kuhn JGJ G
3Phillips JLJ L
4Clark GG
5Ludden TMT M
6Von Hoff DDD D

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antimetabolites, AntineoplasticMajor topic
ArabinonucleotidesMajor topic
Vidarabine PhosphateMajor topic
Agranulocytosis
Biotransformation
Chromatography, High Pressure Liquid
Creatinine
Female
Humans
Kinetics
Male
Metabolic Clearance Rate
Middle Aged

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
N01-CM-27542NCI NIH HHSUnited StatesN01CM027542PubMed and NIHNIH RePORTER
RR-01346NCRR NIH HHSUnited StatesM01RR001346PubMed and NIHNIH RePORTER

Download CSV of grants

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1671222Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.J Pharmacokinet Biopharm1978https://conductscience.org/library/papers/671222PubMed
26966966Comparison of the toxicity and metabolism of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine in human lymphoblastoid cells.Cancer Res1980https://conductscience.org/library/papers/6966966PubMed
3563233Biologic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-beta-D-arabinofuranosyladenine.Biochem Pharmacol1977https://conductscience.org/library/papers/563233PubMed
47214352Activity of mitoxantrone in a human tumor cloning system.Cancer Res1981https://conductscience.org/library/papers/7214352PubMed
56189605Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs.Cancer Treat Rep1983https://conductscience.org/library/papers/6189605PubMed
66204752Phase I clinical investigation of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate (NSC 312887), a new purine antimetabolite.Cancer Res1984https://conductscience.org/library/papers/6204752PubMed
74427218Statistical estimations in pharmacokinetics.J Pharmacokinet Biopharm1974https://conductscience.org/library/papers/4427218PubMed
86254636Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.Cancer Res1980https://conductscience.org/library/papers/6254636PubMed
968603422-fluoro-ATP: a toxic metabolite of 9-beta-D-arabinosyl-2-fluoroadenine.Biochem Biophys Res Commun1983https://conductscience.org/library/papers/6860342PubMed

Download CSV of references

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.

PMIDTitleJournalYearIn PapersSource
34663641Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors.J Immunother Cancer2021https://conductscience.org/library/papers/34663641PubMed
33925713Fludarabine Inhibits Infection of Zika Virus, SFTS Phlebovirus, and Enterovirus A71.Viruses2021https://conductscience.org/library/papers/33925713PubMed
28481355Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplant2017https://conductscience.org/library/papers/28481355PubMed
27094990Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning.Transl Res2016https://conductscience.org/library/papers/27094990PubMed
25986721Integrating oncogeriatric tools into the management of chronic lymphocytic leukemia: current state of the art and challenges for the future.Curr Oncol Rep2015https://conductscience.org/library/papers/25986721PubMed
25983023Association of fludarabine pharmacokinetic/dynamic biomarkers with donor chimerism in nonmyeloablative HCT recipients.Cancer Chemother Pharmacol2015https://conductscience.org/library/papers/25983023PubMed
25354682Tumor-specific suicide gene therapy for hepatocellular carcinoma by transcriptionally targeted retroviral replicating vectors.Gene Ther2015https://conductscience.org/library/papers/25354682PubMed
25047949Targeted enzyme prodrug therapy for metastatic prostate cancer - a comparative study of L-methioninase, purine nucleoside phosphorylase, and cytosine deaminase.J Biomed Sci2014https://conductscience.org/library/papers/25047949PubMed
21992895Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines.BMC Cancer2011https://conductscience.org/library/papers/21992895PubMed
21394111Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase.Cancer Gene Ther2011https://conductscience.org/library/papers/21394111PubMed
20383215High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation.Bone Marrow Transplant2011https://conductscience.org/library/papers/20383215PubMed
19671874A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.Clin Cancer Res2009https://conductscience.org/library/papers/19671874PubMed
18461151Ocular toxicity of fludarabine: a purine analog.Expert Rev Ophthalmol2008https://conductscience.org/library/papers/18461151PubMed
17211431F-ara-A pharmacokinetics during reduced-intensity conditioning therapy with fludarabine and busulfan.Bone Marrow Transplant2007https://conductscience.org/library/papers/17211431PubMed
16012866Accurate measurement of individual glomerular filtration rate in cancer patients: an ongoing challenge.J Cancer Res Clin Oncol2005https://conductscience.org/library/papers/16012866PubMed
11888330Cellular and clinical pharmacology of fludarabine.Clin Pharmacokinet2002https://conductscience.org/library/papers/11888330PubMed
10926348Clinical pharmacokinetics of nucleoside analogues: focus on haematological malignancies.Clin Pharmacokinet2000https://conductscience.org/library/papers/10926348PubMed
10885585Clinical pharmacokinetics of 2'-deoxy-2'-methylidenecytidine (DMDC), a deoxycytidine analogue antineoplastic agent.Clin Pharmacokinet2000https://conductscience.org/library/papers/10885585PubMed
9179529Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.Drugs1997https://conductscience.org/library/papers/9179529PubMed
8137458Pharmacokinetics of the anticancer agent 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine in rats.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8137458PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2427240

GET https://conductscience.org/api/papers/v1/2427240/cited_by?page=2